Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá, Colombia. The new entity, known as 'Seegene Colombia S.A.S,' began operations in mid-October. While the immediate need...
Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific
SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its global offerings and its footprint in the Asia-Pacific (APAC) region with the opening of a new, integrated bioanalytical laboratory in Singapore. The laboratory features new capabilities that enhance the substantial array of...
Qiming’s Portfolio Company Aohua Endoscopy Lands on STAR Market
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Aohua Endoscopy (SHSE: 688212), a leading medical endoscope manufacturer, today landed on the STAR Market. The issue price is CNY 22.5 per share. The stock opened at CNY 33 per share, representing a market cap of CNY 4.4 billion. Qiming Venture Partners led the company's Series C round...
Farrer Park Hospital Announces New Chief Executive Officer (CEO)
SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Farrer Park Hospital Pte Ltd (FPH) announced today the appointment of Dr. Timothy Low as its Chief Executive Officer (CEO). The outgoing CEO (FPH), Dr. Peng Chung Mien, continues as Group CEO of The Farrer Park Company Pte Ltd, which owns FPH and One Farrer Hotel. Dr. Low leaves his...
CBC Group Partners with APG to Launch Healthcare Real Estate Platform and Announce US$500 Million First Close of China Life Science Venture
SHANGHAI, Nov. 15, 2021 /PRNewswire/ --CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm, announced today a partnership with APG Asset Management ("APG"), the largest pension provider in the Netherlands, in a new Asia-Pacific healthcare platform, CBC Healthcare Infrastructure Platform ("CBC HIP") and China-focused life science venture, CBC China Life Science Infrastructure Venture ("CLSIV"). CLSIV has held a first close...
Gannex Announces China NMPA Approved Phase II and III Protocols of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the protocols of Phase II and III clinical trials of ASC42 to treat patients with primary biliary cholangitis (PBC) has been approved by China National Medical Products Administration (NMPA). PBC is a new chronic hepatobiliary disease indication...
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA
BEIJING, Nov. 15, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech company, announced today the Investigational New Drug (IND) clearance of its SHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189 by the US Food and Drug Administration (FDA) for starting clinical trial in the United States. This open, single-arm, multicenter study aims to evaluate...
Antengene Presents Compelling Preclinical Data on Two Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 12, 2021
-ATG-101, a novel PD-L1/4-1BB bispecific antibody, shows potent in vivo anti-tumor efficacy in checkpoint inhibitor resistant/relapsed models while mitigating liver toxicity risk, computational analysis adds support to dosing strategy -ATG-017, an ERK1/2 inhibitor, in vivo combination supports clinical development strategy SHANGHAI and HONG KONG, Nov. 15, 2021 /PRNewswire/ -- Antengene Corporation Limited...
Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy...
SAN FRANCISCO and SUZHOU, China, Nov. 15, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces that the results of the Phase Ib clinical trial of IBI302, a first-in-class ophthalmic recombinant human anti-VEGF and anti-complement bi-specific...
$5M Boost to Innovation in Australia with New Illumina Genomics Lab
New laboratory opens in Melbourne Biomedical Precinct to accelerate the adoption of genomics in healthcare and agriculture in Australia. MELBOURNE, Australia, Nov. 15, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new, fully equipped laboratory to help Australian researchers and entrepreneurs make significant scientific breakthroughs in areas such...
